Carvajal Alejandra 4
4 · Mersana Therapeutics, Inc. · Filed Jan 16, 2025
Insider Transaction Report
Form 4
Carvajal Alejandra
SVP, Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2025-01-14+2,500→ 71,844 total - Exercise/Conversion
Restricted Stock Unit
2025-01-14−2,500→ 2,500 total→ Common Stock (2,500 underlying) - Sale
Common Stock
2025-01-15$0.63/sh−952$600→ 70,892 total
Footnotes (4)
- [F1]Represents shares of common stock received upon vesting of a portion of the restricted stock units ("RSUs") awarded to the Reporting Person on January 14, 2022.
- [F2]Represents the sale of shares of common stock to satisfy the Reporting Person's tax withholding obligations in connection with the service-based vesting and settlement of the RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2023. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the Reporting Person.
- [F3]Each RSU represents the contingent right to receive one share of common stock of the Issuer.
- [F4]25% of the total number of RSUs granted vested on January 14, 2025, and the remainder shall vest on January 14, 2026.